Read + Share
Amedeo Smart
Independent Medical Education
Palaskas NL, Deswal A. In heart failure, adding empagliflozin to medical therapy reduced a composite of CV death or HF hospitalization. Ann Intern Med 2020;173:JC51.PMID: 33197352
Email
LinkedIn
Facebook
Twitter
Privacy Policy